Patrick Dospoy

762 total citations
6 papers, 538 citations indexed

About

Patrick Dospoy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Patrick Dospoy has authored 6 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Patrick Dospoy's work include Lung Cancer Treatments and Mutations (3 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Patrick Dospoy is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Metabolomics and Mass Spectrometry Studies (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Patrick Dospoy collaborates with scholars based in United States, Australia and Japan. Patrick Dospoy's co-authors include Jill E. Larsen, John D. Minna, Ignacio I. Wistuba, Luc Girard, Alexander Augustyn, James P. Sullivan, Carmen Behrens, Adi F. Gazdar, Dhruba Deb and Suzie K. Hight and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Patrick Dospoy

6 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Dospoy United States	5	356	254	180	112	100	6	538
Johannes Fredebohm Germany	12	354 1.0×	210 0.8×	309 1.7×	123 1.1×	91 0.9×	23	581
Allison Goldberg United States	7	322 0.9×	167 0.7×	213 1.2×	48 0.4×	106 1.1×	16	510
Timothy J. Stanek United States	10	458 1.3×	217 0.9×	93 0.5×	53 0.5×	49 0.5×	13	545
Heping Kan China	12	290 0.8×	89 0.4×	221 1.2×	72 0.6×	48 0.5×	18	425
Shoujie Chai China	10	239 0.7×	204 0.8×	143 0.8×	109 1.0×	24 0.2×	12	431
Ernest Medina United States	6	444 1.2×	160 0.6×	80 0.4×	46 0.4×	160 1.6×	9	607
Ailan Cheng China	12	361 1.0×	128 0.5×	134 0.7×	51 0.5×	35 0.3×	28	493
Ranran Kong China	14	331 0.9×	107 0.4×	189 1.1×	67 0.6×	35 0.3×	37	445
Kai‐Yu Ng Hong Kong	9	402 1.1×	130 0.5×	235 1.3×	55 0.5×	43 0.4×	11	542
Chenming Wu China	13	563 1.6×	237 0.9×	101 0.6×	46 0.4×	71 0.7×	22	658

Countries citing papers authored by Patrick Dospoy

Since Specialization

Citations

This map shows the geographic impact of Patrick Dospoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Dospoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Dospoy more than expected).

Fields of papers citing papers by Patrick Dospoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Dospoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Dospoy. The network helps show where Patrick Dospoy may publish in the future.

Co-authorship network of co-authors of Patrick Dospoy

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Dospoy. A scholar is included among the top collaborators of Patrick Dospoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Dospoy. Patrick Dospoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hight, Suzie K., Rahul K. Kollipara, Elizabeth A. McMillan, et al.. (2020). An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis. Neoplasia. 22(8). 294–310. 25 indexed citations

2.

Deb, Dhruba, Satwik Rajaram, Jill E. Larsen, et al.. (2017). Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non–Small Cell Lung Cancers. Cancer Research. 77(11). 3070–3081. 33 indexed citations

3.

Kasiri, Sahba, Baozhi Chen, Paul Yenerall, et al.. (2016). Nonclassical activation of gli1 as a therapeutic target for squamous cell lung cancer. Journal of Thoracic Oncology. 11(2). S28–S28. 1 indexed citations

4.

Larsen, Jill E., Vaishnavi Nathan, Jihan K. Osborne, et al.. (2016). ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. Journal of Clinical Investigation. 126(9). 3219–3235. 260 indexed citations

5.

Lou, Tzu‐Fang, Patrick Dospoy, Hyun Seok Kim, et al.. (2015). Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. Cancer Prevention Research. 9(1). 43–52. 34 indexed citations

6.

Augustyn, Alexander, Mark D. Borromeo, Tao Wang, et al.. (2014). ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proceedings of the National Academy of Sciences. 111(41). 14788–14793. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact